Centro de Estudios Cardiometabólicos S.C. (CESCAM) Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2019
NCT04555447
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Centro de Estudios Cardiometabólicos S.C. (CESCAM)

Active Ingredients

Drugs in Other Trials (1)

agavins (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1